Hci Viocare (VICA) 1.0900 $VICA
HCi Viocare (OTCQB:VICA) files new international patent application for advances in pressure and shear sensing technology
ACCESSWIRE - Wed Dec 16, 10:24AM CST
GLASGOW, SCOTLAND / ACCESSWIRE / December 16, 2015 / UK-based bio-engineering company HCi Viocare Technologies, the developers behind the Smart Insole that monitors diabetic feet, has filed for a new International (PCT) patent application for its pressure and shear sensing technology, which covers over 140 countries around the world. The new patent builds on the company's three UK patent applications filed in December 2014, with further advances made to the sensor systems, and a wider range of applications in products that touch people's everyday lives.
HCi Viocare's (OTCQB:VICA) health tech research centre and P&O clinic opens in Glasgow, UK on the 25th September 2015.
GlobeNewswire - Sat Sep 26, 2:10AM CDT
via PRWEB - HCi Viocare (OTCQB:VICA), (the "Company"
today announced that their cutting edge health tech research centre, set up in Glasgow to develop and commercialize smart sensors that help prevent diabetic foot ulcers and athletic injuries, is being officially opened today by First Minister and local MSP Nicola Sturgeon.
Nicola Sturgeon Opens HCi Viocare's New Glasgow Health Tech Research Centre and Prosthetics and Orthotics Clinic
ACCESSWIRE - Fri Sep 25, 8:30AM CDT
GLASGOW, SCOTLAND / ACCESSWIRE / September 25, 2015 / HCi Viocare (the "Company" (OTCQB: VICA), today announced that their cutting edge health tech research centre, set up in Glasgow to develop and commercialize smart sensors that help prevent diabetic foot ulcers and athletic injuries, is being officially opened today by First Minister and local MSP Nicola Sturgeon.
HCi Viocare Appoints New Non-Executive Board Member
ACCESSWIRE - Thu Jun 18, 8:45AM CDT
ATHENS, GREECE / ACCESSWIRE / June 18, 2015 / HCi Viocare (the "Company" (OTCQB: VICA), announced today that the Board of Directors of the Company has appointed Yannis Levantis as a member of the Board of Directors of the Company. The appointment comes at a time of operational growth for the Company, which is currently establishing a chain of Prosthetic, Orthotic and Diabetic foot rehabilitation centres in Europe, and expanding its R&D portfolio of devices for the larger health & wellness industry.
GSK: 40.33 (-0.24)
HCi Viocare Reveals Wearable Technology for Recreational Runners and Athletes
eTeligis - Wed Mar 11, 10:48AM CDT
ATHENS, Greece, via ETELIGIS INC., 03/09/2015 - - HCi Viocare (the "Company" (OTCQB: VICA), is today unveiling the groundbreaking Smart Insole, a connected product that fits into a training shoe, enabling runners to improve their performance and avoid injury.
HCi Viocare Signs Lease on Premises in Glasgow for its First Viocare Center
ACCESSWIRE - Mon Mar 02, 8:50AM CST
ATHENS, GREECE / ACCESSWIRE / March 2, 2015 / HCi Viocare (the "Company" (OTCQB:VICA), today announced that the HCi Viocare group has entered into a lease agreement for a modern, stand-alone 5,300 square foot facility in Glasgow, Scotland with an entry date of 1 March, 2015.
HCi VioCare Launches New Website and Domain
ACCESSWIRE - Thu Feb 19, 8:45AM CST
ATHENS, GR / ACCESSWIRE / February 19, 2015 / HCi Viocare (OTCQB: VICA), (the "Company" today announced the launch of its new domain and website, with improved functionality, design, and navigation.
Bioengineering Experts HCi Viocare to Unveil Smart Diabetic Insole at ATTD Conference
ACCESSWIRE - Tue Feb 17, 8:03AM CST
ATHENS, GREECE / ACCESSWIRE / February 17, 2015 / HCi Viocare (the "Company" (OTCQB: VICA), today announced that they will be unveiling their smart diabetic insole at the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Paris on the 18th and 19th of February.
HCi Viocare Files Patent Application in Relation to Low-Cost, Portable Motion Capture and Gait Analysis Technology
ACCESSWIRE - Mon Feb 09, 6:38AM CST
ATHENS, GREECE / ACCESSWIRE / February 9, 2015 / HCi Viocare (the "Company" (OTCQB: VICA), is pleased to announce that it has filed a patent application in relation to pioneering low-cost, portable motion capture and gait analysis technology, which has applications in a range of sectors, including athletic wearable devices, physiotherapy, orthotics and potentially also gaming and film.
HCi Viocare Files Patent Application for its Ground-Breaking Shear Sensing Technology
ACCESSWIRE - Wed Feb 04, 9:56AM CST
ATHENS, GREECE / ACCESSWIRE / February 4, 2015 / HCi Viocare (the "Company" (OTCQB: VICA), is pleased to announce that it has filed a patent application for its ground-breaking shear sensing system technology, which supports the development of low cost, flexible and scalable sensor systems in a range of sectors including wearable devices, medical devices (e.g. diabetic foot), Prosthetics & Orthotics and automotive health and safety.
HCi Viocare Files Patent Application for its Innovative Pressure Sensing Technology
ACCESSWIRE - Mon Feb 02, 10:18AM CST
ATHENS, GREECE / ACCESSWIRE / February 2, 2015 / HCi Viocare (the "Company" (OTCQB: VICA), is pleased to announce that it has filed a patent application for its innovative pressure sensing system technology, which supports the development of very low cost, flexible and scalable pressure sensing devices in a range of sectors including wearable devices, Prosthetics & Orthotics, medical devices (e.g. for the diabetic foot), and automotive health and safety.
HCi Viocare Strengthens Management Team with New COO and Investor Relations Executive
ACCESSWIRE - Mon Jan 26, 1:19PM CST
ATHENS, GREECE / ACCESSWIRE / January 26, 2015 / HCi Viocare (OTCQB: VICA), (the "Company" announced today that it has strengthened its management team with the arrival of new COO Heleen Kist and Investor Relations executive Mikulas Dylowicz, who has been retained as a consultant. The appointments come at a time of operational growth for the company, which is setting up a chain of Prosthetic, Orthotic and Diabetic foot rehabilitation centres in Europe and progressing an R&D portfolio of devices for the wider health & wellbeing industry.
HCi VioCare Announces Collaboration Between UK-Based Subsidiary and University of Strathclyde
eTeligis - Tue Oct 07, 11:46AM CDT
GLASGOW, SCOTLAND, United Kingdom, via ETELIGIS INC., 10/07/2014 - - HCi VioCare (OTCQB: VICA), is pleased to announce that its wholly owned UK subsidiary, HCi VioCare Technologies Limited ("HCi VioCare" has entered into an agreement with the Biomedical Engineering Department of the University of Strathclyde in Glasgow, one of the leading Bioengineering and Prosthetics and Orthotics (P&O) research institutes worldwide, to further the development of its innovative technologies through access to the University's laboratory space and machinery.
HCi Viocare (OTCQB:VICA) files new international patent application for advances in pressure and shear sensing technology
ACCESSWIRE - Wed Dec 16, 10:24AM CST
GLASGOW, SCOTLAND / ACCESSWIRE / December 16, 2015 / UK-based bio-engineering company HCi Viocare Technologies, the developers behind the Smart Insole that monitors diabetic feet, has filed for a new International (PCT) patent application for its pressure and shear sensing technology, which covers over 140 countries around the world. The new patent builds on the company's three UK patent applications filed in December 2014, with further advances made to the sensor systems, and a wider range of applications in products that touch people's everyday lives.
HCi Viocare's (OTCQB:VICA) health tech research centre and P&O clinic opens in Glasgow, UK on the 25th September 2015.
GlobeNewswire - Sat Sep 26, 2:10AM CDT
via PRWEB - HCi Viocare (OTCQB:VICA), (the "Company"
today announced that their cutting edge health tech research centre, set up in Glasgow to develop and commercialize smart sensors that help prevent diabetic foot ulcers and athletic injuries, is being officially opened today by First Minister and local MSP Nicola Sturgeon. Nicola Sturgeon Opens HCi Viocare's New Glasgow Health Tech Research Centre and Prosthetics and Orthotics Clinic
ACCESSWIRE - Fri Sep 25, 8:30AM CDT
GLASGOW, SCOTLAND / ACCESSWIRE / September 25, 2015 / HCi Viocare (the "Company"
(OTCQB: VICA), today announced that their cutting edge health tech research centre, set up in Glasgow to develop and commercialize smart sensors that help prevent diabetic foot ulcers and athletic injuries, is being officially opened today by First Minister and local MSP Nicola Sturgeon. HCi Viocare Appoints New Non-Executive Board Member
ACCESSWIRE - Thu Jun 18, 8:45AM CDT
ATHENS, GREECE / ACCESSWIRE / June 18, 2015 / HCi Viocare (the "Company"
(OTCQB: VICA), announced today that the Board of Directors of the Company has appointed Yannis Levantis as a member of the Board of Directors of the Company. The appointment comes at a time of operational growth for the Company, which is currently establishing a chain of Prosthetic, Orthotic and Diabetic foot rehabilitation centres in Europe, and expanding its R&D portfolio of devices for the larger health & wellness industry. GSK: 40.33 (-0.24)
HCi Viocare Reveals Wearable Technology for Recreational Runners and Athletes
eTeligis - Wed Mar 11, 10:48AM CDT
ATHENS, Greece, via ETELIGIS INC., 03/09/2015 - - HCi Viocare (the "Company"
(OTCQB: VICA), is today unveiling the groundbreaking Smart Insole, a connected product that fits into a training shoe, enabling runners to improve their performance and avoid injury. HCi Viocare Signs Lease on Premises in Glasgow for its First Viocare Center
ACCESSWIRE - Mon Mar 02, 8:50AM CST
ATHENS, GREECE / ACCESSWIRE / March 2, 2015 / HCi Viocare (the "Company"
(OTCQB:VICA), today announced that the HCi Viocare group has entered into a lease agreement for a modern, stand-alone 5,300 square foot facility in Glasgow, Scotland with an entry date of 1 March, 2015. HCi VioCare Launches New Website and Domain
ACCESSWIRE - Thu Feb 19, 8:45AM CST
ATHENS, GR / ACCESSWIRE / February 19, 2015 / HCi Viocare (OTCQB: VICA), (the "Company"
today announced the launch of its new domain and website, with improved functionality, design, and navigation. Bioengineering Experts HCi Viocare to Unveil Smart Diabetic Insole at ATTD Conference
ACCESSWIRE - Tue Feb 17, 8:03AM CST
ATHENS, GREECE / ACCESSWIRE / February 17, 2015 / HCi Viocare (the "Company"
(OTCQB: VICA), today announced that they will be unveiling their smart diabetic insole at the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Paris on the 18th and 19th of February. HCi Viocare Files Patent Application in Relation to Low-Cost, Portable Motion Capture and Gait Analysis Technology
ACCESSWIRE - Mon Feb 09, 6:38AM CST
ATHENS, GREECE / ACCESSWIRE / February 9, 2015 / HCi Viocare (the "Company"
(OTCQB: VICA), is pleased to announce that it has filed a patent application in relation to pioneering low-cost, portable motion capture and gait analysis technology, which has applications in a range of sectors, including athletic wearable devices, physiotherapy, orthotics and potentially also gaming and film. HCi Viocare Files Patent Application for its Ground-Breaking Shear Sensing Technology
ACCESSWIRE - Wed Feb 04, 9:56AM CST
ATHENS, GREECE / ACCESSWIRE / February 4, 2015 / HCi Viocare (the "Company"
(OTCQB: VICA), is pleased to announce that it has filed a patent application for its ground-breaking shear sensing system technology, which supports the development of low cost, flexible and scalable sensor systems in a range of sectors including wearable devices, medical devices (e.g. diabetic foot), Prosthetics & Orthotics and automotive health and safety. HCi Viocare Files Patent Application for its Innovative Pressure Sensing Technology
ACCESSWIRE - Mon Feb 02, 10:18AM CST
ATHENS, GREECE / ACCESSWIRE / February 2, 2015 / HCi Viocare (the "Company"
(OTCQB: VICA), is pleased to announce that it has filed a patent application for its innovative pressure sensing system technology, which supports the development of very low cost, flexible and scalable pressure sensing devices in a range of sectors including wearable devices, Prosthetics & Orthotics, medical devices (e.g. for the diabetic foot), and automotive health and safety. HCi Viocare Strengthens Management Team with New COO and Investor Relations Executive
ACCESSWIRE - Mon Jan 26, 1:19PM CST
ATHENS, GREECE / ACCESSWIRE / January 26, 2015 / HCi Viocare (OTCQB: VICA), (the "Company"
announced today that it has strengthened its management team with the arrival of new COO Heleen Kist and Investor Relations executive Mikulas Dylowicz, who has been retained as a consultant. The appointments come at a time of operational growth for the company, which is setting up a chain of Prosthetic, Orthotic and Diabetic foot rehabilitation centres in Europe and progressing an R&D portfolio of devices for the wider health & wellbeing industry. HCi VioCare Announces Collaboration Between UK-Based Subsidiary and University of Strathclyde
eTeligis - Tue Oct 07, 11:46AM CDT
GLASGOW, SCOTLAND, United Kingdom, via ETELIGIS INC., 10/07/2014 - - HCi VioCare (OTCQB: VICA), is pleased to announce that its wholly owned UK subsidiary, HCi VioCare Technologies Limited ("HCi VioCare"
has entered into an agreement with the Biomedical Engineering Department of the University of Strathclyde in Glasgow, one of the leading Bioengineering and Prosthetics and Orthotics (P&O) research institutes worldwide, to further the development of its innovative technologies through access to the University's laboratory space and machinery. 
